Zai Lab Limited Asset Turnover Ratio (ZLAB), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Zai Lab Limited  (NASDAQ: ZLAB)
 

Zai Lab Limited Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Zai Lab Limited's asset turnover ratio has remained unchanged compare to previous quarter at 0.39 in the first quarter (Mar 31 2026)

Within sector 92 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2026, to 1996, from total ranking in the fourth quarter 2025 at 2098.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZLAB Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change -6.61 % 7.57 % 29.26 % 23.87 % 25.5 %
Y / Y Revenue Change -6.46 % 16.99 % 13.52 % 9.43 % 22.19 %
Asset Turnover Ratio (TTM) 0.39 0.39 0.39 0.4 0.41
ZLAB's Total Ranking # 1996 # 2098 # 2230 # 2145 # 2156
Seq. Asset Change -6.54 % 1.16 % -0.44 % -0.79 % 7.65 %
Seq. Revenue Change -21.93 % 9.91 % 5.56 % 3.28 % -2.37 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 93
Healthcare Sector # 321
Overall Market # 1996

Asset Turnover Ratio Statistics
High Average Low
0.39 0.23 0
(Mar 31 2026)   (Dec 31 2018)




ZLAB Company Profile • Back to ZLAB Efficiency Comparisons • Compare ZLAB Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Pro dex Inc   1.14 $ 74.636  Millions$ 65.681  Millions
Puma Biotechnology Inc   1.13 $ 227.178  Millions$ 201.695  Millions
Myomo Inc   1.11 $ 41.180  Millions$ 37.035  Millions
Hims and Hers Health Inc   1.11 $ 2,369.476  Millions$ 2,133.159  Millions
Neuronetics Inc   1.10 $ 150.724  Millions$ 136.777  Millions
Apellis Pharmaceuticals Inc   1.09 $ 1,105.280  Millions$ 1,009.475  Millions
Tarsus Pharmaceuticals Inc   1.09 $ 589.621  Millions$ 543.212  Millions
Longduoduo Co Ltd  1.08 $ 2.132  Millions$ 1.969  Millions
Tandem Diabetes Care Inc   1.08 $ 1,023.420  Millions$ 946.224  Millions
Phibro Animal Health Corporation  1.08 $ 1,500.123  Millions$ 1,388.110  Millions
Harvard Bioscience Inc   1.08 $ 84.970  Millions$ 79.024  Millions
Biodesix Inc   1.07 $ 96.096  Millions$ 89.644  Millions
Inspire Medical Systems inc   1.07 $ 915.060  Millions$ 857.151  Millions
Treace Medical Concepts Inc   1.07 $ 207.318  Millions$ 194.429  Millions
Vaso Corporation  1.05 $ 88.990  Millions$ 84.597  Millions
Axsome Therapeutics Inc   1.04 $ 708.236  Millions$ 678.112  Millions
Milestone Scientific Inc   1.03 $ 8.337  Millions$ 8.077  Millions
Arcutis Biotherapeutics Inc   1.03 $ 415.624  Millions$ 404.097  Millions
Ensysce Biosciences Inc   1.02 $ 4.708  Millions$ 4.594  Millions
Neuroone Medical Technologies Corp  1.02 $ 9.721  Millions$ 9.512  Millions
Axogen inc   1.02 $ 238.105  Millions$ 233.257  Millions
Esperion Therapeutics Inc   1.02 $ 418.244  Millions$ 409.880  Millions
National Vision Holdings Inc   1.02 $ 2,021.044  Millions$ 1,982.746  Millions
Kiniksa Pharmaceuticals International Plc  1.02 $ 754.045  Millions$ 740.599  Millions
Docgo Inc   1.02 $ 301.713  Millions$ 297.094  Millions
Nrc Health  1.01 $ 138.642  Millions$ 136.636  Millions
Addus Homecare Corp  1.01 $ 1,447.070  Millions$ 1,426.219  Millions
Spero Therapeutics Inc   1.00 $ 61.186  Millions$ 61.057  Millions
Premier Air Charter Holdings Inc   1.00 $ 33.205  Millions$ 33.145  Millions
Ensign Group Inc  0.99 $ 5,273.996  Millions$ 5,307.865  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.